Skip to content

DNAlytics

Active
Public limited companyfounded 2012active for 14 yearsAvenue Jean Monnet 1, 1348 Ottignies-Louvain-la-Neuve, Belgium32 active companies are registered at this addressKBO/BCE: BE 0844.973.235
Summary

DNAlytics has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €502,481 and a net result of €118,905. Equity is growing by about 49% per year across the filed financial years. Its solvency ranks better than 59% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Research and development on biotechnology
NACE 72101Engineering and related technical consultancy, excluding land surveyors NACE 71121
1 site
Size
≈ €2.0mturnover 2025, estimated
Staff
8.5 FTE
Equity
€502,481
Profit
€118,905
Turnover estimated from the gross margin
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Largest shareholder
CALLATAY & WOUTERS VENTURES · 12.22%
2025 accounts filed 31 days late1 of 5 deeds summarised
Why 95raises riskLast filed accounts filed 31 days late; 1 of the last 3 latelowers riskSize: total assets €849,953Legal form: public limited companyEquity €502,481 (59.1% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 61% of its sector peers (NACE 72, micro)
Financial strength · tick = 2024
Strong
Solvency 84+16
equity 59.1% of total assets
Liquidity 58-20
short-term debt 23.2% · cash 13.4%
Profitability 86-11
return on assets 14.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.2 percentage points vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.66, compared with 2.38 in 2024, above the usual 1.5; short-term debt: 23.2% and cash: 13.4% of total assets), and 40.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 52% on solvency, 46% on liquidity, 65% on profitability and 81% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Size: total assets €849,953
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Last filed accounts filed 31 days late; 1 of the last 3 late
NBB · filings
lowers risk · Legal form: public limited company
KBO
lowers risk · Equity €502,481 (59.1% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
31 days late
2024
29 days late
2023
27 days late
2022
31 days early
2021
5 days early
2020
26 days late
2019
54 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 19 days after the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (4 of the last 5 filed years within 33 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Equity above €500,000equity €502,481 ▲31%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, abbreviated format

2025 annual accounts filed late (31 days) Filed on 31 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00474001.

Turnover
≈ €2.0m
Estimated: probably between €1.2m and €3.4m
EBIT margin
Not included in this filing
Net result
€118,905▼ 41.1%
2024 · €201,962
Working capital
€129,280▼ 54.5%
2024 · €283,842
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result falls in 2025; 2025 is 39% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€132,718 2025 Net result€118,905 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 72, Scientific research and development: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result-€322,571--€232,780▲ 27.8%€36,809€273,453▲ 643%-€49,602€48,799€216,688▲ 344%€132,718▼ 38.8%
Net result-€342,746--€253,863▲ 25.9%€15,377within the sector's middle half€246,627above the sector's middle half▲ 16×-€58,824below the sector's middle half€39,671within the sector's middle half€201,962above the sector's middle half▲ 409%€118,905above the sector's middle half▼ 41.1%
Equity-€255,373--€266,736▼ 4.4%-€251,359below the sector's middle half▲ 5.8%-€4,732below the sector's middle half▲ 98.1%€141,944within the sector's middle half€181,614within the sector's middle half▲ 27.9%€383,576within the sector's middle half▲ 111%€502,481within the sector's middle half▲ 31.0%
Total assets€353,941-€337,009▼ 4.8%€356,573within the sector's middle half▲ 5.8%€531,924within the sector's middle half▲ 49.2%€747,945above the sector's middle half▲ 40.6%€770,199above the sector's middle half▲ 3.0%€898,685above the sector's middle half▲ 16.7%€849,953within the sector's middle half▼ 5.4%
Debt€609,314-€603,746▼ 0.9%€607,932▲ 0.7%€536,656▼ 11.7%€606,001▲ 12.9%€588,584▼ 2.9%€515,108▼ 12.5%€347,472▼ 32.5%
Working capital€69,978-€60,367▼ 13.7%€84,694within the sector's middle half▲ 40.3%€230,766within the sector's middle half▲ 172%€367,942above the sector's middle half▲ 59.4%€313,212above the sector's middle half▼ 14.9%€283,842within the sector's middle half▼ 9.4%€129,280within the sector's middle half▼ 54.5%
Solvency-72.2%--79.1%▼ 7.0pp-70.5%below the sector's middle half▲ 8.7pp-0.9%below the sector's middle half▲ 69.6pp19.0%below the sector's middle half▲ 19.9pp23.6%below the sector's middle half▲ 4.6pp42.7%within the sector's middle half▲ 19.1pp59.1%within the sector's middle half▲ 16.4pp
Current ratio1.43-1.38▼ 0.051.45within the sector's middle half▲ 0.072.86within the sector's middle half▲ 1.413.37within the sector's middle half▲ 0.512.71within the sector's middle half▼ 0.662.38within the sector's middle half▼ 0.321.66within the sector's middle half▼ 0.73
Return on assets (ROA)-96.8%--75.3%▲ 21.5pp4.3%within the sector's middle half▲ 79.6pp46.4%above the sector's middle half▲ 42.1pp-7.9%below the sector's middle half▼ 54.2pp5.2%within the sector's middle half▲ 13.0pp22.5%within the sector's middle half▲ 17.3pp14.0%above the sector's middle half▼ 8.5pp
Staff (FTE)4-4.8▲ 20.0%4.3above the sector's middle half▼ 10.4%4.9▲ 14.0%5.9▲ 20.4%6▲ 1.7%7.8▲ 30.0%8.5within the sector's middle half▲ 9.0%
above within below the middle half of NACE 72, Scientific research and development: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €849,953
Fixed assets €523,398 ▲ 27.8%
Current assets €326,555 ▼ 33.3%
Equity and liabilities €849,953
Equity €502,481 ▲ 31.0%
Debt €347,472 ▼ 32.5%
Debt's share of the balance-sheet total falls from 57.3% to 40.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€329,185▼
2024 · €355,210
Cash flow
€315,372▼
2024 · €340,484
Debt to equity
0.69▼
2024 · 1.34
ROE
23.7%▼
2024 · 52.7%
Interest coverage
27.14▼
2024 · 27.20
Debt ≤ 1 year
€197,275▼
2024 · €205,439
Debt > 1 year
€111,576▼
2024 · €309,670
Income taxes
€1,699▲
2024 · €1,668
Staff costs
€505,605▲
2024 · €490,303
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 34,693 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95.3% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
3.9% stopped otherwise
95.3% still going

For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 34,693 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 53 lines
Balance sheet Code20242025
Assets
Total assets20/58€898,685€849,953▼
Fixed assets21/28€409,404€523,398▲
Intangible fixed assets21€393,698€508,960▲
Tangible fixed assets22/27€6,389€4,949▼
Plant, machinery and equipment23€6,389€4,949▼
Financial fixed assets28€9,318€9,488▲
Current assets29/58€489,280€326,555▼
Amounts receivable within one year40/41€191,702€177,475▼
Trade receivables40€191,702€160,849▼
Other amounts receivable41-€16,626
Cash at bank and in hand54/58€262,294€113,871▼
Deferred charges and accrued income490/1€35,284€35,210▼
Equity and liabilities
Total equity and liabilities10/49€898,685€849,953▼
Equity10/15€383,576€502,481▲
Contributions10/11€207,000€207,000=
Capital10€207,000-
Issued capital100€207,000-
Contributions outside capital11-€207,000
Other1109/19-€207,000
Reserves13€782€782=
Non-distributable reserves130/1€782€782=
Legal reserve130€782-
Reserves not available under the articles1311-€782
Profit (loss) carried forward14€175,794€294,699▲
Amounts payable17/49€515,108€347,472▼
Amounts payable after more than one year17€309,670€111,576▼
Financial debts170/4€104,817€39,952▼
Other amounts payable178/9€204,853€71,624▼
Amounts payable within one year42/48€205,439€197,275▼
Financial debts43€44,858€54,030▲
Other loans439€44,858€54,030▲
Trade debts44€19,943€26,136▲
Suppliers440/4€19,943€26,136▲
Taxes, remuneration and social security45€133,020€111,165▼
Taxes450/3€24,738€37,524▲
Remuneration and social security454/9€108,282€73,641▼
Other amounts payable47/48€7,618€5,943▼
Accrued charges and deferred income492/3-€38,621
Income statement Code20242025
Remuneration, social security and pensions62€490,303€505,605▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€138,522€196,467▲
Other operating charges640/8€457€410▼
Gross operating margin9900€845,970€835,200▼
Operating profit (loss)9901€216,688€132,718▼
Financial income75/76B€1€17▲
Recurring financial income75€1€17▲
Financial charges65/66B€13,059€12,131▼
Recurring financial charges65€13,059€12,131▼
Profit (loss) for the period before taxes9903€203,630€120,604▼
Income taxes67/77€1,668€1,699▲
Profit (loss) for the period9904€201,962€118,905▼
Profit (loss) for the period to be appropriated9905€201,962€118,905▼
Appropriation of the result
Profit (loss) to be appropriated9906€175,794€294,699▲
Profit (loss) brought forward from the previous period14P-€26,168€175,794▲

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Remuneration, social security and pensions62---€331,580€378,144€379,068€490,303€505,605▲ 3.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€94,839€64,058€48,091€50,635€62,302€85,632€138,522€196,467▲ 41.8%
Other operating charges640/8---€348€3,710€454€457€410▼ 10.3%
Gross operating margin9900€143,941€159,907€357,441€656,015€394,554€513,953€845,970€835,200▼ 1.3%
Operating profit (loss)9901-€322,571-€232,780€36,809€273,453-€49,602€48,799€216,688€132,718▼ 38.8%
Financial income75/76B---€25€38€37€1€17▲ 14×
Recurring financial income75€1€19€41€25€38€37€1€17▲ 14×
Financial charges65/66B---€25,549€8,213€7,704€13,059€12,131▼ 7.1%
Recurring financial charges65€19,181€19,913€20,182€25,549€8,213€7,704€13,059€12,131▼ 7.1%
Profit (loss) for the period before taxes9903-€341,751-€252,674€16,668€247,929-€57,777€41,133€203,630€120,604▼ 40.8%
Income taxes67/77€995€1,189€1,291€1,301€1,047€1,462€1,668€1,699▲ 1.8%
Profit (loss) for the period9904-€342,746-€253,863€15,377€246,627-€58,824€39,671€201,962€118,905▼ 41.1%
Profit (loss) for the period to be appropriated9905-€342,746-€253,863€15,377€246,627-€58,824€39,671€201,962€118,905▼ 41.1%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€0.4m€0.3m€0.4m€0.5m€0.7m€0.8m€0.9m€0.8m▼ 5.4%
Fixed assets21/28€0.1m€0.1m€0.09m€0.2m€0.2m€0.3m€0.4m€0.5m▲ 27.8%
Intangible fixed assets21€0.1m€0.1m€0.08m€0.2m€0.2m€0.3m€0.4m€0.5m▲ 29.3%
Tangible fixed assets22/27€0.003m€0.002m€0.002m€0.005m€0.005m€0.01m€0.006m€0.005m▼ 22.5%
Plant, machinery and equipment23---€0.005m€0.005m€0.01m€0.006m€0.005m▼ 22.5%
Financial fixed assets28€0.007m€0.007m€0.007m€0.01m€0.005m€0.005m€0.009m€0.009m▲ 1.8%
Current assets29/58€0.2m€0.2m€0.3m€0.4m€0.5m€0.5m€0.5m€0.3m▼ 33.3%
Amounts receivable within one year40/41€0.1m€0.1m€0.1m€0.3m€0.2m€0.4m€0.2m€0.2m▼ 7.4%
Trade receivables40---€0.3m€0.2m€0.4m€0.2m€0.2m▼ 16.1%
Other amounts receivable41-------€0.02m-
Cash at bank and in hand54/58€0.09m€0.04m€0.1m€0.006m€0.3m€0.09m€0.3m€0.1m▼ 56.6%
Deferred charges and accrued income490/1---€0.04m€0.03m€0.04m€0.04m€0.04m▼ 0.2%
Equity and liabilities
Total equity and liabilities10/49€0.4m€0.3m€0.4m€0.5m€0.7m€0.8m€0.9m€0.8m▼ 5.4%
Equity10/15-€0.3m-€0.3m-€0.3m-€0.005m€0.1m€0.2m€0.4m€0.5m▲ 31.0%
Contributions10/11€0.7m€0.9m€0.9m€0.9m€0.2m€0.2m€0.2m€0.2m=
Capital10----€0.2m€0.2m€0.2m--
Issued capital100----€0.2m€0.2m€0.2m--
Contributions outside capital11---€0.9m---€0.2m-
Other1109/19---€0.9m---€0.2m-
Reserves13€0.001m€0.001m€0.001m€0.001m€0.001m€0.001m€0.001m€0.001m=
Non-distributable reserves130/1---€0.001m€0.001m€0.001m€0.001m€0.001m=
Legal reserve130-----€0.001m€0.001m--
Reserves not available under the articles1311---€0.001m€0.001m--€0.001m-
Profit (loss) carried forward14-€0.9m-€1.2m-€1.2m-€0.9m-€0.07m-€0.03m€0.2m€0.3m▲ 67.6%
Amounts payable17/49€0.6m€0.6m€0.6m€0.5m€0.6m€0.6m€0.5m€0.3m▼ 32.5%
Amounts payable after more than one year17€0.4m€0.4m€0.4m€0.4m€0.5m€0.4m€0.3m€0.1m▼ 64.0%
Financial debts170/4---€0.4m€0.2m€0.2m€0.1m€0.04m▼ 61.9%
Other amounts payable178/9----€0.2m€0.2m€0.2m€0.07m▼ 65.0%
Amounts payable within one year42/48€0.2m€0.2m€0.2m€0.1m€0.2m€0.2m€0.2m€0.2m▼ 4.0%
Financial debts43----€0.01m€0.03m€0.04m€0.05m▲ 20.4%
Other loans439----€0.01m€0.03m€0.04m€0.05m▲ 20.4%
Trade debts44€0.08m€0.05m€0.08m€0.02m€0.02m€0.05m€0.02m€0.03m▲ 31.1%
Suppliers440/4---€0.02m€0.02m€0.05m€0.02m€0.03m▲ 31.1%
Taxes, remuneration and social security45---€0.09m€0.1m€0.09m€0.1m€0.1m▼ 16.4%
Taxes450/3---€0.03m€0.04m€0.05m€0.02m€0.04m▲ 51.7%
Remuneration and social security454/9---€0.06m€0.08m€0.04m€0.1m€0.07m▼ 32.0%
Other amounts payable47/48---€0.01m€0.007m€0.005m€0.008m€0.006m▼ 22.0%
Accrued charges and deferred income492/3-----€0.04m-€0.04m-
Line20182019202020212022202320242025Change
Profit (loss) for the period9904-€342,746-€253,863€15,377€246,627-€58,824€39,671€201,962€118,905▼ 41.1%
+ Depreciation and write-downs630€94,839€64,058€48,091€50,635€62,302€85,632€138,522€196,467▲ 41.8%
Operating cash flow (approximation)-€247,908-€189,805€63,467€297,262€3,478€125,302€340,484€315,372▼ 7.4%
Investment in fixed assets (approximation)--€62,306-€14,755-€142,576-€109,734-€134,360-€274,611-€310,460▼ 13.1%
Change in cash--€44,675€79,270-€113,455€267,916-€188,187€176,121-€148,423-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 14 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 abbreviated format 31-08-2026 2026-00474001
31-12-2024 micro format 29-08-2025 2025-00441069
31-12-2023 micro format 27-08-2024 2024-00388313
31-12-2022 micro format 30-06-2023 2023-00191980
31-12-2021 micro format 26-07-2022 2022-20238600
31-12-2020 micro format 26-08-2021 2021-54800320
31-12-2019 micro format 23-09-2020 2020-55200469
31-12-2018 full format 28-08-2019 2019-53100539
31-12-2017 full format 30-08-2018 2018-54500164
31-12-2016 full format 24-08-2017 2017-46900582

Show all 14 filings

Similar companies · same sector, comparable size

Of the 760 active companies whose main activity is research and development on biotechnology (NACE 72101), figures are known for 484. 318 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Wallonia-Brussels Federation

2021 · 3 entries · €221,091 in total

European research

1 project · 1 as coordinator · €50,000 EU contribution
Programmes
1 entry · €50,000
Projects
Arthritis Differential DIagnostic validaTION
Horizon 2020 · coordinator · 01-04-2015 to 30-09-2015 · €50,000 · ADDITION

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 1 of 5 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

3 owners

Owners 3

Stated earlier (2)

An older source named these owners; newer accounts no longer list them.

Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Capital and shareholders

Shareholders according to the deeds
Stated in the act act of 23-12-2024 ↗
  • HELLEPUTTE Thibault Marc Bernard Frans Marie Ghislain 14,139 shares · 43.7%
  • DUPONT Pierre Raphaël Luc 5,311 shares · 16.4%
  • FINANCIERE GALILEE (BE 0450.895.293) 3,359 shares · 10.4%
  • De CALLATAÿ Didier 3,358 shares · 10.4%
  • VINSOVIER (BE 0733.765.309) 3,110 shares · 9.6%
  • JPP CONSULTING (BE 0829.890.923) 1,375 shares · 4.3%
  • SUASIO (BE 0671.597.217) 600 shares · 1.9%
  • ROULIVE Patrice Henry François 537 shares · 1.7%
  • QUINET Thomas Marie Christian Emile 247 shares · 0.8%
  • KANTOROWICZ Jessica Paula 247 shares · 0.8%
  • GRAMME Pierre Georges Rémy 125 shares · 0.4%
  • LAUWERYS Bernard Robert Jean 90 shares · 0.3%
  • SOPARTEC (BE 0402.978.679) 616 shares
  • FERON Olivier Jean François Christophe 85 shares · 0.3%

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Group and network

Connections & network

Depth

The network starts from this company’s shareholders. What else they own or run appears here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

DNAlytics was incorporated on 3 April 2012.1 Total assets rose from €353,941 in 2018 to €849,953 in 2025 and headcount from 4 to 8.5 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
31-08
NBB filing Annual accounts filed
financial year 2025 · abbreviated format · 31 days late
2025
31-12
Financial Equity above €500,000equity €502,481 ▲31%
3 profitable years in a row build equity to €502,481.
29-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 29 days late
2024
31-12
Financial Equity above €200,000equity €383,576 ▲111%
2 profitable years in a row build equity to €383,576.
23-12
Gazette deed Purpose · Amendment of the articles · Resignations & appointments
Shareholding · Financial instrument26 facts ▸
  • General meeting, 17-12-2024
  • Other provision, “secrétaire et scrutateur, président” (deed in French)
  • Shareholding, “registre des actions nominatives”, 14139 (deed in French)
  • Shareholding, “registre des actions nominatives”, 5311 (deed in French)
  • Shareholding, “registre des actions nominatives”, 3359 (deed in French)
  • Shareholding, “registre des actions nominatives”, 3358 (deed in French)
  • Shareholding, “registre des actions nominatives”, 3110 (deed in French)
  • Shareholding, “registre des actions nominatives”, 1375 (deed in French)
  • Shareholding, “registre des actions nominatives”, 600 (deed in French)
  • Shareholding, “registre des actions nominatives”, 537 (deed in French)
  • Shareholding, “registre des actions nominatives”, 247 (deed in French) (2 times)
  • Shareholding, “registre des actions nominatives”, 125 (deed in French)
  • +14 further facts in this act
27-08
NBB filing Annual accounts filed
financial year 2023 · micro format · 27 days late
2023
31-12
Financial Back to profitnet €39,671
Net result €39,671 after one loss-making year.
31-12
Financial Equity above €150,000equity €181,614 ▲27.9%
Equity rises from €141,944 to €181,614.
30-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial Equity above €100,000equity €141,944
Equity rises from -€4,732 to €141,944.
26-07
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Highest result from 2018 to 2025net €246,627 ▲1,504%
Operating result €273,453, net result €246,627, both a record.
Show earlier events
26-08
NBB filing Annual accounts filed
financial year 2020 · micro format · 26 days late
2020
31-12
Financial Back to profitnet €15,377
Net result €15,377 after 2 loss-making years.
23-09
NBB filing Annual accounts filed
financial year 2019 · micro format · 54 days late
2019
28-08
NBB filing Annual accounts filed
financial year 2018 · full format · 28 days late
2018
30-08
NBB filing Annual accounts filed
financial year 2017 · full format · 30 days late
2017
24-08
NBB filing Annual accounts filed
financial year 2016 · full format · 24 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 14 annual accounts filed, the latest 10 are here; all 14 are under Financials.
1 of 5 deeds read
About the unread acts

Of the 5 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPublic limited company
Founded03-04-2012
Financial year end31-12
Activities, NACEBEL 2025
71121Engineering and related technical consultancy, excluding land surveyors
72101Research and development on biotechnology
62100Computer programming
70200Business and other management consultancy
Contact
E-mail info@dnalytics.com
E-invoicing
Reachable via Peppol
Peppol ID 0208:0844973235
Registered 25-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Ottignies-Louvain-la-Neuve · 1 establishment unit since 2012
registered office establishment The establishment unit on the map
Ground area
8.8 ha
Building footprint
654 m²
Building volume
3,995 m³
Parcel 25384A0101/00W000, Wallonia · tallest building 8.9 m. Linked by address, not a title deed.
32 companies at this address See who is registered here
1 establishment unit
DNAlytics
Avenue Jean Monnet 1, 1348 Ottignies-Louvain-la-NeuveResearch and development on biotechnology
since 2012unit no. 2.208.810.457
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
25384A0101/00W000 Wallonia 8.8 ha 1 · 654 m² 8.9 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

Other provisionsOther rules from the articles that fall under none of the themes above.
Other provision: “Quorum modification des statuts, délibérer sur une modification des statuts” (deed in French)
1 more provision in the deed, see the deed of 23-12-2024

Read from the deeds: 2 provisions, deed of 23-12-2024